We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

161 hedge funds and large institutions have $373M invested in Spectrum Pharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 70 increasing their positions, 22 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

443% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 7

218% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 22

26% more capital invested

Capital invested by funds: $296M → $373M (+$77.1M)

23% more funds holding

Funds holding: 131 → 161 (+30)

20% less call options, than puts

Call options by funds: $646K | Put options by funds: $810K

Holders
161
Holders Change
+30
Holders Change %
+22.9%
% of All Funds
4.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
70
Reduced
22
Closed
7
Calls
$646K
Puts
$810K
Net Calls
-$164K
Net Calls Change
+$204K

Top Buyers

Rank Fund Capital Flow
1
Macquarie Group
Macquarie Group
Australia
+$14.2M
2
Renaissance Technologies
Renaissance Technologies
New York
+$8.86M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$6.15M
4
State Street
State Street
Massachusetts
+$5.06M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.66M

Top Sellers

Rank Fund Capital Flow
1
KAM
Krensavage Asset Management
New York
-$6.95M
2
PAM
Panagora Asset Management
Massachusetts
-$1.06M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$959K
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$619K
5
CCM
Cadence Capital Management
Massachusetts
-$412K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFA
1
BlackRock Fund Advisors
California
$39.3M +$222K +31,370 +0.5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$37M +$2.82M +398,719 +8%
Renaissance Technologies
3
Renaissance Technologies
New York
$29.9M +$8.86M +1,254,017 +38%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$27.9M – – –
Macquarie Group
5
Macquarie Group
Australia
$21.7M +$14.2M +2,009,407 +155%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$18M +$4.66M +658,825 +32%
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$13.9M +$6.15M +869,854 +70%
State Street
8
State Street
Massachusetts
$12.8M +$5.06M +715,546 +58%
BIT
9
BlackRock Institutional Trust
California
$12.4M +$492K +69,580 +4%
Deutsche Bank
10
Deutsche Bank
Germany
$11.3M +$2.53M +358,304 +26%
Goldman Sachs
11
Goldman Sachs
New York
$10.3M +$773K +109,338 +7%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$9.11M +$1.15M +162,704 +13%
Barclays
13
Barclays
United Kingdom
$6.69M +$178K +25,175 +3%
TA
14
Teachers Advisors
New York
$6.67M +$368K +52,136 +5%
Charles Schwab
15
Charles Schwab
California
$6.39M +$480K +67,894 +8%
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$6.38M +$441K +62,428 +7%
PAM
17
Panagora Asset Management
Massachusetts
$6.32M -$1.06M -149,637 -13%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$5.08M -$206K -29,088 -4%
Northern Trust
19
Northern Trust
Illinois
$5.04M -$78.2K -11,064 -1%
EA
20
Emerald Acquisition
Washington
$4.81M +$5.17M +731,467 New
Invesco
21
Invesco
Georgia
$4.38M +$2.24M +316,368 +90%
Wells Fargo
22
Wells Fargo
California
$3.8M +$60.4K +8,551 +2%
TCIM
23
TIAA CREF Investment Management
New York
$3.05M +$744K +105,308 +29%
Prudential Financial
24
Prudential Financial
New Jersey
$2.9M +$2.13M +301,100 +215%
Principal Financial Group
25
Principal Financial Group
Iowa
$2.89M +$157K +22,257 +5%
1
2 3 4 5

SPPI Hedge Fund Activity: Q2 2016 in Review

161 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2016, worth a combined $373M — up 26% from $296M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new SPPI positions and 7 closed out — a net gain of 31 holders — while 70 added to existing stakes and 22 trimmed.

The largest buyer was Macquarie Group, adding an estimated $14.2M. The largest seller was Krensavage Asset Management, exiting entirely with an estimated $6.95M sold.

  • 161 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2016, up from 131 in Q1 2016.
  • Funds reported $373M of Spectrum Pharmaceuticals Inc stock for Q2 2016, up 26% quarter-over-quarter.
  • 38 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2016 and 7 closed out, a net change of +31 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2016 was Macquarie Group, an estimated $14.2M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2016 was Krensavage Asset Management, an estimated $6.95M sold.

Based on aggregated 13F filings for Q2 2016.